24 Nov 2021 --- The South Africa Health Products Regulatory Authority (SAHPRA) has issued a positive outcome for the fixed dose combination of levofloxacin and dexamethasone multidose eye drops. The license and rights of the patented formula was granted to Italy-based NTC and Aspen Pharmacare Holdings, a South African specialty and branded pharmaceutical company. This covers the commercialization of the formula in South Africa and other African countries.
